Aurora CannabisNASDAQ: ACB

NASDAQ | TSX: ACB Outgoing Chairman Ron Funk appointed Lead Independent Director, as part of Board leadership transition EDMONTON, AB , Sept. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced the appointments of CEO Miguel Martin to the additional role of Executive Chairman and outgoing Chairman Ron Funk as Lead Independent Director.

24/7 Wall St. Insights A Kamala Harris victory in the 2024 presidential election could provide a boost for stocks in a variety of sectors.

Many legal cannabis operators are working to keep pushing the boundaries of the industry. Innovation is key for any growing sector and cannabis is no different. Right now is a pivotal time for the cannabis industry as things are continuously changing. The climate of the sector and the success of companies can have a direct connection to how most marijuana stocks perform, especially during an election year where promises may come along from presidential candidates to better the industry.

When it comes to finding top marijuana stocks to buy which companies would you choose? Now when going through this process there are some things to consider. For the most part, investing in all things is based on the same basic outline which is buy low sell high do your research create a game plan be patient, and try to take profits when you can.

Aurora Cannabis Inc (NASDAQ:ACB) and Lumen Technologies Inc (NYSE:LUMN) are this week's picks for Schaeffer's Cheap Seats : Stocks Under $20 segment.

Investing in top marijuana stocks in 2024 can be a bit of a challenge. Sometimes it can be tough knowing which companies to consider and when to take action. For many no matter the sector investing is a skill that takes time to get right. To begin if you are new to marijuana stocks some factors to keep in mind. Most of the sector operates with a large amount of volatility.

Company's Long-Standing Investment in the Region Continues with Enhanced Local Production and Domestic Cultivar Research EDMONTON, AB , July 25, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canadian-based global medical cannabis company, has been granted two licenses by the Federal Institute for Drugs and Medical Devices (BfArM) under Germany's new Medical Cannabis Act (MedCanG). Aurora's license grants the company continued domestic cultivation, which has been underway for two years now.

Aurora Cannabis has three big strikes against it. The Canada-based cannabis company does have a few good things going for it, though.

Investing in the stock market can be a highly rewarding pursuit. However, it also brings an oasis of risks.